Former Practice Fusion Sales Executive

PA 2026 Independent Pharmacies
OIG Controlled Substance Obstruction
Penalty
$0

Outcome

OIG enforcement action against Former Practice Fusion Sales Executive for controlled substance, obstruction.

Details

Former Practice Fusion Sales Executive — OIG Enforcement (2026)

OIG took enforcement action against Former Practice Fusion Sales Executive in PA in 2026 involving controlled substance, obstruction violations in the Independent Pharmacies sector.

Violation types: Controlled Substance, Obstruction
Entity type: Healthcare Provider
Penalty type: Criminal
Location: PA

Source: Former Practice Fusion Sales Executive Pleads Guilty To Obstructing Government Investigations Into Purdue Pharma And Practice Fusion

How Crucible Prevents This

Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping. Crucible's immutable audit trail prevents records from being altered or destroyed, and its document retention enforcement ensures compliance with record-keeping requirements.

Source: Former Practice Fusion Sales Executive Pleads Guilty To Obstructing Government Investigations Into Purdue Pharma And Practice Fusion

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works